92 filings
8-K
MNMD
Mind Medicine Inc
8 May 24
MindMed Reports First Quarter 2024 Financial Results and Business Updates
4:10pm
8-K
MNMD
Mind Medicine Inc
1 Apr 24
MindMed Announces Voluntary Delisting from Cboe Canada
5:03pm
8-K
MNMD
Mind Medicine Inc
11 Mar 24
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
8:32am
8-K
MNMD
Mind Medicine Inc
7 Mar 24
Regulation FD Disclosure
8:19am
8-K
MNMD
Mind Medicine Inc
7 Mar 24
Mindmed Receives Fda Breakthrough Therapy Designation
6:56am
8-K
8ipxawbsec3d
28 Feb 24
MindMed Reports 2023 Financial Results and Business Updates
7:15am
8-K
mhf6bn okt1
8 Jan 24
MindMed Announces Business Update and Anticipated Milestones for 2024
8:00am
8-K
h7jfwyv
14 Dec 23
MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120
7:57am
8-K
pktr0x2
2 Nov 23
MindMed Reports Third Quarter 2023 Financial Results and Business Highlights
4:15pm
8-K/A
tq776z
15 Sep 23
Other Events
5:27pm
8-K/A
1prfzapvfdtgrrcs
15 Sep 23
Other Events
5:23pm
8-K
y30f ca5o
14 Aug 23
Company Logo MindMed Investor Presentation August 2023
4:31pm
8-K
9x8ynhge
14 Aug 23
Entry into a Material Definitive Agreement
8:31am
8-K
4k72t94knpyjy 5k
3 Aug 23
MindMed Reports Second Quarter 2023 Financial Results and Business Highlights
4:19pm
8-K/A
8zh5xdkql
25 Jul 23
Submission of Matters to a Vote of Security Holders
5:14pm
8-K
pefh1ugig0kg0fc mw
27 Jun 23
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
6la6it81wzcjp5
20 Jun 23
Regulation FD Disclosure
4:36pm
8-K
0qzfe0g
16 Jun 23
Other Events
5:06pm
8-K
9gmuabnjllrhx8
15 Jun 23
MindMed Adjourns Annual General Meeting of Shareholders
4:50pm
8-K
oadkp1kk5yasxp a734
24 May 23
MindMed to Present Data on the Preclinical Activity of MM-402 at the American Society of Clinical Psychopharmacology (ASCP) 2023 Annual Meeting
8:31am